The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Steroids

• Publication date

  2016-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.steroids.2016.03.006PMID 26980146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics, 2012

  2015cited by this paper
• Thyroid hormone regulation of metabolism.

  2014cited by this paper
• Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective.

  2013cited by this paper
• Caspase-2 as a tumour suppressor

  2013cited by this paper
• Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy.

  2012cited by this paper
• Pharmacodynamic Modeling of Anti-Cancer Activity of Tetraiodothyroacetic Acid in a Perfused Cell Culture System

  2011cited by this paper
• Thyroid Hormone Is a MAPK-Dependent Growth Factor for Human Myeloma Cells Acting via αvβ3 Integrin

  2011cited by this paper
• p53R2 Inhibits the Proliferation of Human Cancer Cells in Association with Cell-Cycle Arrest

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• KRAS-mediated up-regulation of RRM2 expression is essential for the proliferation of colorectal cancer cell lines.

  2011cited by this paper
• Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab

  2010cited by this paper
• Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid.

  2010cited by this paper
• Colorectal cancer

  2010cited by this paper
• Implications for KRAS status and EGFR-targeted therapies in metastatic CRC

  2009cited by this paper
• Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.

  2009cited by this paper
• p21 in cancer: intricate networks and multiple activities

  2009cited by this paper
• Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells.

  2006cited by this paper
• Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor.

  2004cited by this paper
• Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase.

  2001cited by this paper
• Thyroxine Promotes Association of Mitogen-activated Protein Kinase and Nuclear Thyroid Hormone Receptor (TR) and Causes Serine Phosphorylation of TR*

  2000cited by this paper
• The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.

  1999cited by this paper
• Thyroid hormone promotes the phosphorylation of STAT3 and potentiates the action of epidermal growth factor in cultured cells.

  1999cited by this paper
• Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells.

  1999cited by this paper
• Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells.

  1999cited by this paper
• Identification of c-MYC as a target of the APC pathway.

  1998cited by this paper
• Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation.

  1994cited by this paper
• Integrin (cid:1) V (cid:2) 3 Contains a Cell Surface Receptor Site for Thyroid Hormone that Is Linked to Activation of Mitogen-Activated Protein Kinase and Induction of Angiogenesis

  year unknowncited by this paper

• Stromal cells in normal colon and colon cancers: importance of thyroid hormone signaling

  2025cites this paper
• Breast cancer cells utilize T3 to trigger proliferation through cellular Ca2+ modulation

  2024cites this paper
• Risk of Subsequent Primary Cancers in Thyroid Cancer Survivors according to the Dose of Levothyroxine: A Nationwide Cohort Study

  2024cites this paper
• Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition.

  2022cites this paper
• Thyroid hormone signaling in the intestinal stem cells and their niche

  2022cites this paper
• The power of heteronemin in cancers

  2022cites this paper
• Thyroid hormone receptor α1 acts as a new squamous cell lung cancer diagnostic marker and poor prognosis predictor

  2021cites this paper
• Melatonin Enhances the Chemosensitivity of Pancreatic Carcinoma Cells (PANC-1) to Cisplatin and Cetuximab through modulation of p21, p27, p53, p57, MDM2 and KRAS Genes

  2021cites this paper
• Nano-Strategies Targeting the Integrin αvβ3 Network for Cancer Therapy

  2021influential citation
• Nano-Targeting of Thyrointegrin αvβ3 Receptor in Solid Tumors and Impact on Radiosensitization

  2021cites this paper
• Selective Inhibition of Genomic and Non-Genomic Effects of Thyroid Hormone Regulates Muscle Cell Differentiation and Metabolic Behavior

  2021cites this paper
• Role of thyroid hormone-integrin αvβ3-signal and therapeutic strategies in colorectal cancers

  2021influential citation
• Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells

  2020cites this paper
• NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer

  2020cites this paper
• MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance

  2020cites this paper
• NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells.

  2019cites this paper
• Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis

  2019cites this paper
• The Role of Thyroid Hormones in Hepatocyte Proliferation and Liver Cancer

  2019cites this paper
• Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status

  2019cites this paper
• Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical Studies

  2019cites this paper
• Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy

  2019cites this paper
• Thyroid Hormone Promotes β-Catenin Activation and Cell Proliferation in Colorectal Cancer

  2018influential citation
• Nonthyroidal Illness Syndrome and Thyroid Hormone Actions at Integrin αvβ3.

  2018cites this paper
• Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers

  2018cites this paper
• Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells.

  2018cites this paper
• Mechanisms of action of nonpeptide hormones on resveratrol‐induced antiproliferation of cancer cells

  2017cites this paper
• Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer.

  2017cites this paper
• Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.

  2017cites this paper
• Maternal bisphenol A alters fetal endocrine system: Thyroid adipokine dysfunction.

  2016cites this paper
• Thyroid Hormone, Cancer, and Apoptosis.

  2016cites this paper